Clinical trials
Terminated Hyperlipoproteinemia Type II trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 3 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 3 |
| Ferrer Internacional S.A. | 2 |
| Medical Research Laboratories International | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Columbia University | 1 |
| French Cardiology Society | 1 |
| Organon and Co | 1 |
| Pfizer | 1 |
| REGENXBIO Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipoproteinemia Type II | 13 |
| Homozygous Familial Hypercholesterolemia | 3 |
| Atherosclerosis | 1 |
| Cardiovascular Diseases | 1 |
| Genetic Diseases, Inborn | 1 |
| Hypercholesterolemia | 1 |
| Hyperlipidemias | 1 |
| Lipid Metabolism, Inborn Errors | 1 |
| Metabolic Diseases | 1 |
| Non-alcoholic Fatty Liver Disease | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.